Lupin Limited and Mylan Pharmaceuticals Inc. have collaborated to launch Lupin’s biosimilar Nepexto (etanercept) in the German market. The partnership to bring Nepexto to Germany was announced shortly after the biosimilar was approved by the European Medicines Agency.
Lupin And Mylan Launch Etanercept in Germany
Germany First European Market For Nepexto
In partnership with Lupin, Mylan introduces Nepexto (etanercept) to the German market. After adalimumab, Nepexto is Mylan’s second immunology product in Germany.
